This study is testing a new treatment called AZD0754 CAR T-cell therapy for people with advanced prostate cancer. This therapy involves using a patient’s own immune cells to fight cancer. The study will help understand if this treatment is safe and effective. Participants must be over 18 and have specific types of prostate cancer. They should have tried other treatments without success. Some medical conditions might disqualify someone from participating.

• Length of Study: The study includes multiple phases, and participants will need to be available for a period that could extend over several weeks or months.
• Participation Requirements: Regular visits will be necessary for treatment and monitoring.
• Potential Risks: As with any medical study, there are possible risks, which will be explained by the research team.

Consider discussing with your doctor to see if this study is right for you and if you meet the eligibility criteria. Participants will receive close medical supervision, and any side effects will be managed by the study doctors.